Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 5,599 | 5,309 | 4,184 | 6,634 | 4,490 |
| Gross Profit | 5,599 | 5,309 | 4,184 | 6,634 | 4,490 |
| Operating Expenses | 37,649 | 38,626 | 36,070 | 34,893 | 33,678 |
| Operating Income | -32,050 | -33,317 | -31,886 | -28,259 | -29,188 |
| Other Income | 3,505 | 3,389 | 3,000 | 2,490 | 1,875 |
| Pre-tax Income | -28,545 | -29,928 | -28,886 | -25,769 | -27,313 |
| Income Tax | 942 | 560 | N/A | 0 | N/A |
| Net Income Continuous | -29,487 | -30,488 | -28,886 | -25,769 | -27,313 |
| Net Income | $-29,487 | $-30,488 | $-28,886 | $-25,769 | $-27,313 |
| EPS Basic Total Ops | -0.70 | -0.73 | -0.69 | -0.62 | -0.66 |
| EPS Basic Continuous Ops | -0.71 | -0.73 | -0.69 | -0.62 | -0.66 |
| EPS Diluted Total Ops | -0.70 | -0.73 | -0.69 | -0.62 | -0.66 |
| EPS Diluted Continuous Ops | -0.71 | -0.73 | -0.69 | -0.62 | -0.66 |
| EBITDA(a) | $-31,905 | $-33,228 | $-31,612 | $-27,843 | $-28,701 |